| Date Filed | Type | Description |
| 01/24/2023 |
4
| MacLean Michael F (CFO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 18,500 shares
@ $0
Granted 148,000 options to buy
@ $22.47, valued at
$3.3M
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| MacLean Michael F (CFO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 131,250 options to buy
@ $14.22, valued at
$1.9M
|
|
| 06/21/2021 |
4
| MacLean Michael F (Director) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Granted 47,664 options to buy
@ $19, valued at
$905.6k
|
|
| 06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
3
| MacLean Michael F (CFO) has filed a Form 3 on Avidity Biosciences, Inc. |
| 01/16/2020 |
4
| MacLean Michael F (CFO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 28,000 shares
@ $0 |
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2019 |
4
| MacLean Michael F (CFO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/04/2019 |
4
| MacLean Michael F (CFO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 83,000 options to buy
@ $30.73, valued at
$2.6M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| MacLean Michael F (CFO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 332,708 options to buy
@ $18.65, valued at
$6.2M
|
|
| 09/05/2017 |
3
| MacLean Michael F (CFO) has filed a Form 3 on AKCEA THERAPEUTICS, INC. |
| 10/04/2010 |
4
| MacLean Michael F (SVP, Chief Accounting Officer) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 953 shares
@ $56.53, valued at
$53.9k
|
|
| 08/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/20/2010 |
4/A
| MacLean Michael F (SVP, Chief Accounting Officer) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Sold 3,757 shares
@ $60, valued at
$225.4k
|
|
| 03/23/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/25/2010 |
4
| MacLean Michael F (SVP, Chief Accounting Officer) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Granted 3,990 shares
@ $0
Paid exercise price by delivering 423 shares
@ $55.29, valued at
$23.4k
Paid exercise price by delivering 427 shares
@ $55.29, valued at
$23.6k
Granted 6,114 restricted stock units
@ $0 |
|
| 02/17/2010 |
4
| MacLean Michael F (SVP, Chief Accounting Officer) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 1,127 shares
@ $55.21, valued at
$62.2k
Paid exercise price by delivering 875 shares
@ $55.21, valued at
$48.3k
|
|
| 01/19/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2009 |
4
| MacLean Michael F (SVP, Chief Accounting Officer) has filed a Form 4 on BIOGEN IDEC INC. |
| 10/05/2009 |
4
| MacLean Michael F (SVP, Chief Accounting Officer) has filed a Form 4 on BIOGEN IDEC INC. |
| 02/26/2009 |
4
| MacLean Michael F (SVP, Chief Accounting Officer) has filed a Form 4 on BIOGEN IDEC INC. |